Dr Ian Fallis
Prosiectau fel Prif Ymchwiliwr
1 o 5
- 18F-Gemcitabine as diagnostic tool in personalised chemotherapy (01.06.2017 - 31.10.2018)
- Biological amplification of chemical warfare agent sensors - Towards deviceless devices (01.11.2012 - 31.03.2014)
- Development for chemical detection in IMASS and swabs with BBI detection (01.02.2016 - 31.12.2022)
- Development of antibody-directed, metal-based diagnostic, positron emission tomography (PET) imaging and therapeutic agents through ion complexation and superparamagnetic iron oxide metal oxide nanoparticles (01.01.2014 - 31.12.2018)
- Easy-to-use test kits for toxic chemical identification (01.10.2008 - 30.09.2009)
Prosiectau fel Cyd-Ymchwiliwr
1 o 5
- Asymmetric synthesis of chiral cubanes (01.04.2024 - 31.08.2027)
- Biomaterial modulation for diagnostic and therapeutic benefit in catheter-associated urinary tract infection (01.10.2017 - 30.04.2023)
- CBR hazard mitigation - Multifuncitonal reactive microemulsions (01.12.2012 - 31.03.2013)
- Combating antimicrobial resistance via microwave treatment of morphologically distinct nanoparticles (01.08.2016 - 31.12.2016)
- Construction of 18F-perfluorinated motifs by mechanistic leverage with fluorine (22.04.2021 - 21.07.2024)
Setiau Data Ymchwil
Thomson Reuters Deutschland GmbH
Zur Giesserei 2
D-76227 Karlsruhe | Germany